Is TTK Healthcare the Best Stock in Its Sector? A Look at the Numbers

Is TTK Healthcare the best stock in its sector? The stock trades on the NSE at Rs 1,004 as of 09 October 2026, within its 52-week range of Rs 735.00 to Rs 1,247.00. TTK Healthcare Ltd sells consumer products such as Woodward's Gripe Water, Eva, Good Home and Skore, which account for about 31 percent of revenue.

TTK Healthcare sits in the Healthcare sector, and its 5.89% ROE and 19.28x P/E give a starting point for judging where it stands against comparable listed names. The rest of this article compares those numbers against verified peers and the sector's Industry P/E benchmark.

Also read – Is Abbott India the Best Stock in Its Sector? A Look at the Numbers

Click Here – Get Free Investment Predictions

About TTK Healthcare

TTK Healthcare Ltd sells consumer products such as Woodward's Gripe Water, Eva, Good Home and Skore, which account for about 31 percent of revenue. Promoter T T Jagannathan passed away on 9 October 2025, a leadership change investors have followed. The stock trades about 19 percent below its 52-week high and about 37 percent above its 52-week low. At a market capitalisation of Rs 1,426 Cr, it is tracked as part of the Healthcare sector on Univest.

Is TTK Healthcare the Best Stock in Its Sector?

TTK Healthcare's case rests on valuation and balance sheet strength rather than returns. TTK Healthcare's 19.28x P/E is below the 23.61x Industry P/E and debt is negligible at 0.02, but a 5.89% ROE is low, so the stock looks reasonable on the earnings multiple rather than on returns.

Metric	TTK Healthcare
CMP (NSE)	Rs 1,004.40
52-Week High / Low	Rs 1,247.00 / Rs 735.00
Market Cap	Rs 1,426 Cr
P/E (TTM) vs Industry P/E	19.28x vs 23.61x
P/B	1.28
ROE	5.89%
EPS (TTM)	Rs 52.34
Dividend Yield	0.99%
Debt to Equity	0.02

Compare TTK Healthcare Against Other Healthcare Sector Stocks

How TTK Healthcare Compares Against Its Healthcare Sector Peers

The table below sets TTK Healthcare against 2 other Healthcare sector names, using the same live data source for every company. A peer average row is included for P/E, ROE and debt to equity, calculated across the 2 peer companies.

Company	Market Cap (Rs Cr)	P/E	ROE	Debt to Equity
TTK Healthcare	1,426	19.28	5.89%	0.02
Amrutanjan Health Care	1,458	27.01	17.42%	0.00
FDC	5,281	18.05	11.32%	0.01
Peer average (2 companies)	-	22.53	14.37%	0.01

Against this peer set, TTK Healthcare's 5.89% ROE is below the 14.37% peer average, and its P/E of 19.28x runs below the peer average of 22.53x. TTK Healthcare's 19.28x P/E is below the 23.61x Industry P/E and debt is negligible at 0.02, but a 5.89% ROE is low, so the stock looks reasonable on the earnings multiple rather than on returns.

What Makes TTK Healthcare Worth Watching in Healthcare

• Debt free balance sheet: A debt to equity ratio of 0.02 means interest costs barely touch earnings.
• Recognised brands: Woodward's Gripe Water, Eva, Good Home and Skore give the consumer products arm brand recall.
• Low ROE: A 5.89% ROE is the main weakness against a modest valuation discount.

TTK Healthcare Valuation: Is It Justified?

TTK Healthcare's 19.28x P/E is below the 23.61x Industry P/E and debt is negligible at 0.02, but a 5.89% ROE is low, so the stock looks reasonable on the earnings multiple rather than on returns. As with any single stock, investors should weigh this against their own valuation discipline and risk appetite rather than the sector label alone.

Also read – Is Total Transport Systems the Best Stock in Its Sector? A Look at the Numbers

Download the Univest iOS App or Univest Android App to track TTK Healthcare and other Healthcare sector stocks.

How to Track TTK Healthcare Before You Invest

Before deciding whether TTK Healthcare deserves its label as the best stock in its sector for your own portfolio, compare it directly against Healthcare sector peers using the steps below.

1. Open the Univest Screener and search for TTK Healthcare to view live price, valuation ratios, and peer comparisons within the Healthcare sector.
2. Compare its P/E, P/B, and ROE against other Healthcare sector stocks before deciding if the current valuation fits your strategy.
3. Set a price alert around key support and resistance zones using the Univest app so you are notified of meaningful moves.
4. Open a broking account on Univest if you decide to add the stock, and size the position based on your own risk appetite and portfolio allocation.

Conclusion

TTK Healthcare is worth researching mainly on valuation, with a P/E of 19.28x against a 23.61x Industry P/E, but a 5.89% ROE is modest, so the case for calling it the best stock in its sector rests on more than current returns. As with any individual stock decision, this analysis is educational and investors should do their own research or consult a SEBI-registered advisor before investing.

Is TTK Healthcare the best stock in its sector?

Ans. TTK Healthcare has a 5.89% ROE and trades at 19.28x P/E against a 23.61x Industry P/E, and compares below the peer average ROE of 14.37% in this article's named comparison, so the answer depends on what an investor is prioritising.

What is the current share price of TTK Healthcare?

Ans. TTK Healthcare was trading at Rs 1,004.40 on the NSE as of 09 October 2026, within its 52-week range of Rs 735.00 to Rs 1,247.00.

What sector does TTK Healthcare belong to?

Ans. TTK Healthcare is classified under the Healthcare sector on Univest.

How does TTK Healthcare compare to its sector peers on P/E?

Ans. TTK Healthcare's P/E of 19.28x is below the 22.53x average of the 2 named peers compared in this article.

What is TTK Healthcare's return on equity?

Ans. TTK Healthcare reported a return on equity of 5.89%, which is below the 14.37% average of its named peers in this comparison.

Should I invest in TTK Healthcare based on its sector position?

Ans. TTK Healthcare's sector position and metrics make it worth researching further, but any investment decision should factor in your own risk appetite, its valuation relative to peers, and independent research or advice from a SEBI-registered advisor.

{"@context": "https://schema.org", "@type": "FAQPage", "mainEntity": [{"@type": "Question", "name": "Is TTK Healthcare the best stock in its sector?", "acceptedAnswer": {"@type": "Answer", "text": "TTK Healthcare has a 5.89% ROE and trades at 19.28x P/E against a 23.61x Industry P/E, and compares below the peer average ROE of 14.37% in this article's named comparison, so the answer depends on what an investor is prioritising."}}, {"@type": "Question", "name": "What is the current share price of TTK Healthcare?", "acceptedAnswer": {"@type": "Answer", "text": "TTK Healthcare was trading at Rs 1,004.40 on the NSE as of 09 October 2026, within its 52-week range of Rs 735.00 to Rs 1,247.00."}}, {"@type": "Question", "name": "What sector does TTK Healthcare belong to?", "acceptedAnswer": {"@type": "Answer", "text": "TTK Healthcare is classified under the Healthcare sector on Univest."}}, {"@type": "Question", "name": "How does TTK Healthcare compare to its sector peers on P/E?", "acceptedAnswer": {"@type": "Answer", "text": "TTK Healthcare's P/E of 19.28x is below the 22.53x average of the 2 named peers compared in this article."}}, {"@type": "Question", "name": "What is TTK Healthcare's return on equity?", "acceptedAnswer": {"@type": "Answer", "text": "TTK Healthcare reported a return on equity of 5.89%, which is below the 14.37% average of its named peers in this comparison."}}, {"@type": "Question", "name": "Should I invest in TTK Healthcare based on its sector position?", "acceptedAnswer": {"@type": "Answer", "text": "TTK Healthcare's sector position and metrics make it worth researching further, but any investment decision should factor in your own risk appetite, its valuation relative to peers, and independent research or advice from a SEBI-registered advisor."}}]}